Diabetes mellitus is a common immune mediated disorder. The aim of the present study is to evaluate the level of serum and salivary IgA levels in patients with Type 1 diabetes.
Material and Method
In this case control study, serum and salivary IgA levels of patients with diabetes type 1 and similar non diabetes subjects were measured. Age, gender, duration of diabetes and the last HbA1c level of diabetic patients were also studied. Data was analyzed by SPSS software.
Two hundred and fifty subjects (126 diabetics and 124 non diabetics) were enrolled in the study. The mean value of serum IgA in patients with Type 1 Diabetes and controls was 1.77± 1.55 g/lit and 2.39± 1.52 g/lit, respectively. The mean salivary IgA level in diabetics and controls was 276 ± 162.5 40 μg/ml and 129 ± 112.2 40 μg/ml, respectively. Selective IgA deficiency was detected in two (1.6%) and three(2.4%)cases of diabetic and control group; respectively (p=0.68). We found low salivary IgA level in 44.4% diabetic and 33.9% control (p=0.08). There was no significant correlation between serum and salivary IgA level. There was also significant association between serum IgA levels with age. Salivary IgA was significantly correlated with HbA1c level. But considering gender, duration of diabetes we didn’t find any association.
Citation: Ahmadiafshar A, Mohsenifard MR, Mazloomzadeh S (2015) Evaluation of Serum & Salivary IgA in Patients with Type 1 Diabetes. PLoS ONE 10(4): e0122757. https://doi.org/10.1371/journal.pone.0122757
Academic Editor: Massimo Pietropaolo, University of Michigan Medical School, UNITED STATES
Received: September 28, 2014; Accepted: January 27, 2015; Published: April 13, 2015
Copyright: © 2015 Ahmadiafshar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: All relevant data are within the paper.
Funding: This study was supported by (Zanjan University of Medical Sciences) after being approved by the research council of ZUMS and permission of the ethic committee of ZUMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Selective IgA deficiency is the most common primary immunodeficiency. Its incidence varies depending on ethnic background from 1/143 to 1/185000 in different geographic areas . It is usually asymptomatic. However, these patients are more susceptible to frequent infections, autoimmune disorders, gastrointestinal diseases and atopy. It seems that, the increased frequency of infections associated with IgA deficiency could therefore precipitate autoimmune disease such as systemic lupus erythematus, Graves' disease, celiac, recurrent parotiditis, inflammatory bowel syndrome, Crohn's disease, juvenile idiopathic arthritis and type 1 diabetes [1–5]. Some studies showed the role of some related genes that was found in IgA deficiency and some autoimmune disorders.. Furthermore, there was little evidence about the role of secretory IgA as a first line defense in prevention of these disorders. One study showed lower Secretory IgA in diabetic patients,  but some studies did not show any significant changes in salivary IgA of diabetes patients.[8,9]. On the other hand, association between serum and secretory IgA remain to be explored. The aim of this study was to investigate and compare serum and salivary IgA level in type I diabetic patients and non diabetic controls.
Materials and Methods
This prospective case control study was conducted in Diabetes Clinic of Valie Asr hospital and registry of Diabetic Society of Zanjan, Zanjan, Iran, between April 2012 to February 2013. Patients with type1 diabetes were selected and consecutively enrolled to study. The diagnosis of diabetes was made on the basis of diagnostic criteria of The American Diabetes Association  Patients with any diabetic complications and subjects with ages lower than 5 years, having Acute or chronic infectious, inflammatory, endocrine and immunologic disorders and those who had received anticonvulsive drugs, penicilamine and non steroidal anti inflammatory drugs at least 4 weeks before study were excluded. The control group was selected from healthy accompanying non relative voluntaries or medical staff of the hospital.
Specimen collection, handling and testing
This Study was approved by Ethics Research Committee of Zanjan University of Medical Sciences and at the beginning of study all the participants or their parents assigned the informed consent form. After that, blood and salivary samples were collected from patients and controls. In each case 2 ml of whole blood was collected by venipuncture, centrifuged and serum samples were stored at -70°C for serum IgA determination. Serum IgA concentration were determined by nephelometry method (MININEPH TM Human IgA Kit, the binding Site Ltd, Birmingham, UK). The saliva samples were also obtained by spitting out to a glass tube and centrifuged at 3000 rpm for 15 minutes to remove any particulate material and then supernatants were immediately frozen at -20°C and stored for secretory IgA assessment. Quantitative assessment of IgA in saliva was determined by ELISA method (Dia Metra, Milano, Italy). Information on age, gender, duration of disease and the last HbA1c was compiled using questionnaires. Selective IgA deficiency was considered based on serum IgA level lower than 0.07 gr/l . Normal range of salivary IgA was 40–170 on the basis of Diametra kit (Dia Metra, Milano, Italy), thus, the cut off point for IgA deficiency in serum and saliva was ≤0.07 gr/l and ≤40 μg/ml, respectively.
The Kolmogorov-Smirnov test was used to evaluate the distribution of quantitative variables. Values were expressed as number (percentage), and mean±standard deviation, as appropriate. Comparisons were performed by chi-square test for categorical variables, independent T-test for normally distributed, and Mann–Whitney test for non-normally distributed. Pearson's and Spearman correlation coefficient were calculated for assessment of correlation between quantitative and qualitative variables, respectively. A multivariate logistic regression model was used to examine the association between the independent and dependent variables. Differences with a p value less than 0.05 were accepted as statistically significant. All statistical analyses were performed using the SPSS PC version 16.0 computer software program for Windows (SPSS, Chicago, IL, USA).
One hundred and twenty six type 1 diabetic patients and 124 healthy controls were recruited to study. The mean age of patients and controls was 24.2 ±13.1 and 29.8 ± 11.7 respectively (p = 0.0001). The male to female ratio of patients and controls was similar (p = 0.62). The mean serum IgA concentration in Diabetic patients was significantly lower than control group (p<0.0001), but after adjusting for age using logistic regression this association was not significant.
We didn't find any significant difference in salivary IgA levels in patients and controls (p = 0.724). (Table 1)
Two (1.6%) and three(2.4%)cases in diabetic and control group; respectively had selective IgA deficiency (p = 0.68). Furthermore, the frequency of low salivary IgA in patients (44.4%) and control (33.9%) was not statistically significant (p = 0.08) (Table 1).
The correlation of serum IgA with age in control subjects was significant (r = 0.301, = 0.001) but its relation with gender was not significant (r = -0.1, P = 0.29).
We found significant correlation between serum IgA and age in diabetics (r = 0.24, p = 0.007) but its association with gender, duration of disease and HbA1c in diabetic group was not statistically significant. (Table 2)
The correlation between Salivary IgA with HbA1c in diabetics was significant (p = 0.003) but its association with age, gender, duration of disease was not statistically significant. (Table 3)
One subject with IgA deficiency in diabetics and all 3 IgA deficient cases in control group, had low salivary IgA level, however, the correlation between serum and salivary IgA in both groups was not significant (r = 0.1, P = 0.25).
Although, some studies showed higher rate of IgA deficiency in diabetic patients [2,18], in our study the frequency of selective IgA deficiency in patient and control groups was similar. Genetic susceptibility and ethnic background or the method of selection or sampling of study population might be explained these differences. Therefore further investigations in this area could be clarified it.
Although, several studies showed an elevated mean of serum IgA concentration in type 1 and type2 diabetic patients specially for those with complications compared to controls.[18–22] in our study the mean of serum IgA concentration in diabetics was lower than control. Absence of infection, complications or other autoimmune disorders in our patients could be explained this contrary result.
Serum IgA is in monomeric form, whereas two third of IgA located in mucosal areas is secretary IgA and has dimeric form. It has an important role in protection of mucociliary areas and plays as a barrier against pathogenic organisms, antigens and even allergens, thus any defect in this defense system could be an important risk factor for development of autoimmune disorders and allergy or increasing the susceptibility to infection. [1,23] Some evidence support that there is a complex interaction between the intestinal microorganisms and the immune system in the maintenance of the normal immune homeostasis in the gut. Changes in gut micro flora in susceptible individuals could lead to alternation in the gut immune system such as increased gut permeability, impaired tolerance to food, intestinal inflammation and Islet cell destruction [24–26]. Our study did not show any significant difference in salivary IgA in diabetic and control group, furthermore there was no significant correlation between serum and salivary IgA levels in study groups. Rashkova and colleagues showed similar results , however several studies demonstrated higher salivary IgA in diabetic patients. [8,21,27] Bhuyan and coworker showed lower level of salivary IgA in diabetes specially uncontrolled diabetic patients, in spite of the higher serum IgA levels in diabetic individuals. .
The regulation of secretion and synthesis of secretory IgA not only is dependent on antigenic stimulation, but is also under strong neuroendocrine control. Thus, alterations in neuroendocrine function such as; stress, exercise, pregnancy, menstrual cycle, may affect salivary IgA levels [23,28]. Secretory IgA level also directly increased with age even in healthy subjects.  In our study the serum IgA level was significantly associated with age of individuals. (Table 2), However salivary IgA had no significant correlation with age. (Table 3)
In our study about one third and one forth of diabetic and non diabetic subjects, respectively had low salivary IgA (salivary IgA <40 μg/ml) level. According to different method of collection, induction of saliva and doubt about the standard level of IgA in saliva, there was not documented data about low salivary IgA in literature.  Lamb and coworkers found a significant association between cow's milk protein intake and islet cell autoimmunity and type1 diabetes in children with low/moderate genetic type 1 diabetes risk . Therefore it seems that, mucosal immunity might play an important protective role against diabetes.
Immunologic status of diabetic patients specially antibody production may be impaired in high glucose concentration.  We found significant correlation between salivary IgA and HbA1c levels. However, serum IgA levels did not have significant correlation with HbA1c and the period of disease. Our study finding was compatible with study of Sayarifard and colleagues, which did not found any association between serum IgA and HbA1c levels. 
In conclusion, this study showed the lower mean serum IgA levels in diabetic patients but after adjustment with age it was not significant. In addition, the salivary IgA levels in patients and controls did not differ significantly. There was no significant correlation between serum and salivary IgA. We also found higher frequency of selective IgA deficiency and low salivary IgA in our study subjects. Therefore, further investigations for finding causal factors and assessment of health status of our population might be meaningful. With respect to the risk of potential anaphylactic reaction to transfusion of blood product, recognition and screening of these patients could be beneficial.
This study was part of post-graduated thesis of Dr Mahmood Reza Mohsenifard and was supported by the Zanjan University of Medical Science. The authors would like to thank Dr Faranak Sharifi, Dr Parisa Khoshnevis, Dr Majid Valizadeh and Dr Mitra Maaboudi for their valuable helps during the study.
Conceived and designed the experiments: AA MRM SM. Performed the experiments: AA MRM. Analyzed the data: SM. Contributed reagents/materials/analysis tools: SM. Wrote the paper: AA.
- 1. Yel L. Selective IgA deficiency. J Clin Immunol. 2010;30 (1): 6–10
- 2. Wang N, Shen N, Vyse TJ, Anand V, Gunnarson I, Sturfelt G, et al. Selective IgA deficiency in autoimmune diseases. Mol Med. 2011;17 (11–12):1383–1396
- 3. Jorgensen GH, Gardulf A, Sigurdsson MI, Sigurdardottir ST, Thorsteinsdottir I, Gudmundsson S, et al. Clinical Symptoms in Adults with Selective IgA Deficiency: A Case-Control Study. J Clin Immunol. 2013; 33 (4):742–747 pmid:23389234
- 4. Moise A, Nedelcu FD, Toader MA, Sora SM, Tica A, Frastraoaro DE, et al. Primary immunodeficiencies of the B lymphocyte. J Med Life. 2010;3 (1): 60–63.
- 5. Moradinejad MH, Rafati AH, Ardalan M, Rabiei M, Farghadan M, Ashtiani MT, et al. Prevalence of IgA deficiency in children with juvenile rheumatoid arthritis. Iran J Allergy Asthma Immunol. 2011;10 (1):35–40. pmid:21358013
- 6. Wang N, Hammarström L. IgA deficiency: what is new? Curr Opin Allergy Clin Immunol. 2012;12 (6): 602–608. pmid:23026772
- 7. Branco-de-Almeida LS, Alves CM, Lopes FF, Pereira Ade F, Guerra RN, Pereira AL. Salivary IgA and periodontal treatment needs in diabetic patients. Braz Oral Res. 2011;25 (6):550–555 pmid:22147237
- 8. Bakianian Vaziri P, Vahidi M, Mortazavi H, Abdollahzadeh Sh, Hajilooi M. Evaluation of salivary glucose, IgA and flow rate in diabetic patients: a case-control study. J Dent (Tehran). 2010;7 (1): 13–18.
- 9. Rashkova M, Baleva M, Toneva N, Peneva M, Perenovska P, Koprivarova K. Secretory immunoglogulin A (S-IgA) in the Saliva of children with Type 1 Diabetes, Asthma, Systemic Health and Systemic Health but Wearing Removable Orthodontic Appliances. OHDMBSC. 2009; 8 (2): 16–24.
- 10. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2010; 33 (suppl 1): S62–S69. pmid:20042775
- 11. Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol. 2005; 94 (5 suppl1): S1–63.
- 12. Baştürk B, Sari S, Aral A, Dalgiç B. Prevalence of selective immunoglobulin A deficiency in healthy Turkish school children. Turk J Pediatr.2011; 53 (4): 364–368
- 13. Chandran S, Khetan D, Chaudhary R, Misra R, Aggarwal A. Low prevalence of IgA deficiency in north Indian population. Indian J Med Res. 2006;123 (5):653–656. pmid:16873907
- 14. Feng ML, Zhao YL, Shen T, Haung H, Yin B, Liu RZ, et al. Prevalence of immunoglobulin A deficiency in Chinese blood donors and evaluation of anaphylactic transfusion reaction risk. Transfus Med. 2011; 21 (5): 338–343. pmid:21658139
- 15. Palmer DS, O'Toole J, Montreuil T, Scalia V, Yi QL, Goldman M, et al. Screening of Canadian Blood Services donors for severe immunoglobulin A deficiency. Transfusion. 2010;50 (7):1524–1531 pmid:20158683
- 16. Saghafi S, Pourpak Z, Aghamohammadi A, Pourfathollah AA, Samadian A, Farghadan M, et al. Selective immunoglobulin A deficiency in Iranian blood donors: prevalence, laboratory and clinical findings. Iran J Allergy Asthma Immunol 2008;7 (3): 157–162. pmid:18780950
- 17. Sayarifard F, Aghamohammadi A, Haghi-Ashtiani MT, Rajab A, Irani H, Ahmadian JH, et al. Evaluation of serum IgA levels in Iranian patients with type 1 diabetes mellitus. Acta Diabetol. 2012;49 (2): 131–135 pmid:20411282
- 18. Bhuyan SK, Mody RN, Bhuyan R. Estimation and Comparison of Serum and Salivary IgA Levels in Controlled, Uncontrolled Diabetics and Normal Individuals. Journal of Indian Academy of Oral Medicine and Radiology, 2011; 23 (4): 548–553
- 19. Ohmuro H, Tomino Y, Tsushima Y, Shimizu M, Kuramoto T, Koide H. Elevation of Serum. IgA1 Levels in Patients with Diabetic Nephropathy. Nephron 1993;63 (3):355 pmid:8446278
- 20. Rodriguez-Segade S, Camifia MF, Carnero A, Lorenzo MJ, Alban A, Quinteiro C, et al. High serum IgA concentrations in patients with diabetes mellitus: agewise distribution and relation to chronic complications. Clin Chem. 1996;42 (7): 1064–1067 pmid:8674189
- 21. Svensson J, Eising S, Mortensen HB, Christiansen M, Laursen I, Lernmark Å, et al. High levels of immunoglobulin E and a continuous increase in immunoglobulin G and immunoglobulin M by age in children with newly diagnosed type 1 diabetes. Hum Immunol.2012;73 (1): 17–25.
- 22. Moazezi Z, Hosseinian A, Ahmad Moazam E, Eslami MB, Mosavi E, Akhavan-Niaki H, et al. Evaluation of immunological parameters in diabetic patients: are these patients immunodeficient? Iran J Allergy Asthma Immunol. 2014;13:110–119. pmid:24338256
- 23. Fagerås M, Tomičić S, Voor T, Björkstén B, Jenmalm M. Slow salivary secretory IgA maturation may relate to low microbial pressure and allergic symptoms in sensitized children. Pediatr Res. 2011; 70 (6): 572–577. pmid:21857384
- 24. Peng J, Narasimhan S, Marchesi JR, Benson A, Wong FS, Wen L. Long term effect of gut microbiota transfer on diabetes development. J Autoimmun. 2014;53:85–94.
- 25. Zipris D. The interplay between the gut microbiota and the immune system in the mechanism of type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2014; 20:265–270.
- 26. Dunne JL, Triplett EW, Gevers D, Xavier R, Insel R, Danska J, et al. The intestinal microbiome in type 1 diabetes. Clin Exp Immunol. 2014; 77:30–37.
- 27. Belazi MA, Galli-Tsinopoulou A, Drakoulakos D, Fleva A, Papanayiotou PH. Salivary alterations in insulin-dependent diabetes mellitus. Int J Paediatr Dent. 1998;8 (1):29–33 pmid:9558543
- 28. Teeuw W, Bosch JA, Veerman EC, Amerongen AV. Neuroendocrine regulation of salivary IgA synthesis and secretion: implications for oral health. Biol Chem. 2004;385 (12): 1137–1146. pmid:15653426
- 29. Jafarzadeh A, Sadeghi M, Karam GA, Vazirinejad R. Salivary IgA and IgE levels in healthy subjects: relation to age and gender. Braz Oral Res. 2010;24 (1):21–27.
- 30. Bokor-Bratić M. Clinical significance of analysis of immunoglobulin A levels in saliva. Med Pregl. 2000;53 (3–4): 164–168
- 31. Lamb MM, Miller M, Seifert JA, Frederiksen B, Kroehl M, Rewers M, et al. The effect of childhood cow's milk intake and HLA-DR genotype on risk of islet autoimmunity and type 1 diabetes: The Diabetes Autoimmunity Study in the Young. Pediatr Diabetes. 2015; 16(1):31–8 pmid:24444005
- 32. Sakowicz-Burkiewicz M, Kocbuch K, Grden M, Maciejewska I, Szutowicz A, Pawelczyk T. High glucose concentration impairs ATP outflow and immunoglobulin production by human peripheral B lymphocytes: involvement of P2X7 receptor. Immunobiology. 2013; 218 (4):591–601. pmid:22883563